MedTrace Logo

RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer

NCT04069884 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 540

Last updated 2025-09-22

No results posted yet for this study

Summary

The purpose of this study is to validate whether clinically low-risk, and RecurIndex high-risk N1 patients receiving regional lymph node radiotherapy can further improve clinical outcomes.

Conditions

Interventions

RADIATION

regional nodal irradiation

external-beam radiotherapy (XRT)

RADIATION

WBI

Whole Breast Irradiation

RADIATION

chestwall XRT

chestwall irradiation

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-20
Primary Completion
2029-08-20
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04069884 on ClinicalTrials.gov